46 3 
Home Page  

  • SciELO

  • Google
  • SciELO
  • Google


Anales del Sistema Sanitario de Navarra

 ISSN 1137-6627

        18--2024

https://dx.doi.org/10.23938/assn.1051 

Case Report

Successful outpatient conservative management of chyle leak after laparoscopic left hemicolectomy

Éxito de tratamiento conservador ambulatorio de paciente con ascitis quilosa tras hemicolectomía izquierda laparoscópica

Laura Rubio-López (orcid: 0000-0002-8678-4824)1  , Conceptualization, Writing - Original Draft; Silvia Benito-Barbero (orcid: 0000-0001-7733-1711)1  , Writing - Review and Editing; Javier Páramo-Zunzunegui (orcid: 0000-0002-4308-0501)1  2  , Conceptualization; Teresa Antón-Bravo3  , Writing - Review and Editing; María Moral-González (orcid: 0000-0002-6384-6471)1  4  , Conceptualization, Writing - Review and Editing

1.Servicio de Cirugía General y del Aparato Digestivo. Hospital Universitario de Móstoles. Móstoles. Madrid. España

2.Universidad Rey Juan Carlos. Facultad de Ciencias de la Salud. Departamento de Especialidades Médicas y Salud Pública. Alcorcón. Madrid. España

3.Servicio de Endocrinología y Nutrición. Hospital Universitario de Móstoles. Móstoles. Madrid. España

4.Universidad Francisco de Vitoria. Majadahonda. Madrid. España

ABSTRACT

Chyle leak is a pathological extravasation of chyle into the peritoneal cavity after a surgical injury. It is an uncommon complication in colorectal surgery. In most cases, conservative treatment is effective, although it often entails prolonged hospital stays.

We present the case of a 60-year-old female with chyle leak after laparoscopic left hemicolectomy with complete mesocolic excision who underwent successful outpatient conservative management. We found no other cases of successful conservative outpatient treatment in the consulted literature. Adequate outpatient management may provide significant benefits by reducing hospital costs and improving patient’s quality of life, while maintaining the possibility of starting adjuvant treatment if indicated.

Keywords: Chylous ascites; Food formulated; Enteral nutrition; Colorectal neoplasms

RESUMEN

La ascitis quilosa es una acumulación patológica de quilo en la cavidad peritoneal tras una lesión quirúrgica. Es una complicación infrecuente de la cirugía colorrectal. En la mayoría de los casos, el tratamiento conservador suele ser eficaz, aunque conlleva estancias hospitalarias prolongadas.

Se presenta el caso de una paciente de 60 años que desarrolló ascitis quilosa tras una hemicolectomía izquierda laparoscópica, con escisión completa del mesocolon, que se resolvió con éxito mediante manejo conservador ambulatorio. No se han encontrado casos exitosos de tratamiento conservador ambulatorio en la bibliografía consultada. Un manejo ambulatorio como el propuesto puede aportar importantes beneficios en términos de reducción de costes hospitalarios y mejora de la calidad de vida del paciente, manteniendo la posibilidad de iniciar un tratamiento adyuvante si está indicado.

Palabras clave: Ascitis quilosa; Alimentos formulados; Nutrición enteral; Cáncer colorrectal

INTRODUCTION

Postoperative chyle leak (CL) is an uncommon complication of colorectal surgery related to iatrogenic trauma to lymphatic vessels. The reported incidence of CL is between 1% and 6.6%1-5; however, incidence is increasing due to the rise of more extensive lymphadenectomies5-7. There are different terminologies and diagnostic criteria for CL in the literature. The generally accepted criteria of CL are a leak debit > 200 mL/day and triglyceride levels > 110-200 mg/dL or 2-8 times the plasma concentration1-4.

CL may lead to dehydration, malnutrition, immunosuppression, and longer hospital stays1,2,6; moreover, it delays adjuvant chemotherapy with the consequent increased risk of disease recurrence due to the potential spread of cancer cells into the CL5,8. Hence the importance of an early diagnosis and treatment initiation.

We present the first described case of successful outpatient treatment of postoperative CL.

CASE REPORT

A 60-year-old female with no relevant medical history nor abdominal symptoms was diagnosed of partially stenosing sigmoid adenocarcinoma after a colonoscopy following a positive faecal occult blood test. A thoracic-abdominopelvic computed tomography revealed suspicious lymphadenopathy (Figura 1).

Figure 1. A coronal computed tomography image shows circumferential parietal thickening causing luminal stenosis (arrow). Regional lymph nodes are also observed, the largest (asterisk) of 16 mm for the long axis diameter and suspicious for malignancy. 

The patient underwent a laparoscopic left hemicolectomy with complete mesocolic excision by ligation with hem-o-lok’s® (Weck, Teleflex) at the origin of the inferior mesenteric artery and vein and electrodissection with Thunderbeat® (Olympus). The pathological study showed a moderately differentiated sigmoid adenocarcinoma (histological grade 2), with free surgical borders and metastasis in one of the 21 isolated lymph nodes, with pathological stage IIIB (pT3 pN1a).

After the reintroduction of normal oral diet, on Day 2 post-surgery, the intra-abdominal drain output turned milky and increased in quantity, approximately 500 mL/day (Fig. 2). Clinically, the patient showed no fever and no signs of peritoneal irritation or infection, suggesting anastomotic leakage or other intra-abdominal infection.

Figure 2. Chyle ascites drainage obtained on Day 2 post-surgery. 

The analysis of the drainage fluid showed elevated triglyceride concentration (2,036 mg/dL), protein 3g/dL, lactic dehydrogenase 306 IU/L, amylase 16U/L, and glucose 140 mg/dL. Cytology for malignancy was negative, as well as the microbiological cultures. Postoperative chyle leak was diagnosed due to the lack of other major findings.

A strict fat-free oral diet supplemented with medium-chain triglycerides and subcutaneous octreotide (0.1 mg/8 hours) was started. On Day 4 post-surgery, the patient was offered outpatient management with intra-abdominal drainage and nursing, surgical, and nutritional follow-up. Progressive decrease of the drainage’s debit was observed. One week after the beginning of the conservative treatment, drainage fluid was 250 mL/day debit with a triglyceride concentration of 327 mg/dL. The drainage was clamped with ultrasound monitoring of the intra-abdominal fluid at baseline, and on Day 4 and Day 8 post-clamping. No increase in intra-abdominal fluid was observed; the drainage was removed on Day 13 post-surgery.

Regular oral diet was progressively reintroduced without incidents. Simultaneously, the patient started adjuvant chemotherapy treatment following the schedule. Two years later, the patient remains asymptomatic with no evidence of CL or tumour recurrence.

DISCUSSION

The diagnosis of postoperative CL is usually achieved rapidly by observing a milky discharge in the intra-abdominal drainage after reintroducing the oral diet5, as in our case. However, routine use of prophylactic drainage has no benefits in colorectal surgery3. Thus, in the absence of drainage, the patient presents postoperative abdominal distention and pain. To reach a CL diagnosis, an abdominal computed tomography (CT) is needed, in which massive ascites are identified, followed by paracentesis and ascitic fluid analyses5.

Many risk factors have been described for the development of CL after colorectal surgery1. The most prominent is tumour location, as CL is more frequent after right colectomies2,4-7, opposite to the case presented here. Other risk factors are advanced age2, short operating time2,3, and extensive lymphadenectomy3-5,7. The incidence of CL has increased due to the rise in the number of complete mesocolic excisions (CME) in colorectal surgery5,7, as in our patient. In addition, the type of used surgical technique and surgical energy devices seem to influence the occurrence of lymphatic leakage. The likelihood of a CL may be higher with the use of electrocautery and ultrasonic devices in comparison to ligatures or hemoclips2,10. In our patient, vascular clips and advanced energy (Thunderbeat®) were used.

At the hospital, conservative treatment for postoperative CL provides successful resolution in 66-77% of the cases1,11. This treatment either consists of fasting -with the administration of total parenteral nutrition- or a strict oral diet (high in protein, fat-free, and rich in medium-chain triglycerides, MCTs) to reduce lymphatic flow1,2,9,10,12. In our case, a strict oral fat-free diet supplemented with MCTs was indicated. Several brands of enteral formulas containing MCTs are commercially available or alternatively, liquid oil or capsulated MCTs. The usual adult dose is 50 to 100 mL/day12. The administration of somatostatin analogues may be helpful, although evidence remains unclear1,2,12,13. Some researchers hold that they can reduce lymphatic production and directly induce the contraction of the lymphatic vessels by acting on lymphatic vessel receptors of the gastrointestinal tract1,2, but the evidence is still limited5. We administered subcutaneous (0.1 mg/8 hours) octreotide (a somatostatin analogue for only four days, as no reduction in drainage’s debit was observed.

There is no established length for the conservative therapy. However, if the leak persists after 6-8 weeks, the conservative therapy should be regarded as a failure and surgery considered. The most commonly used surgical treatment is repair under direct vision. For intraoperative location of the lymphatic leak, preoperative administration of high-fat food, lymphangiography, or indocyanine green injection are helpful.1-3,8-11,13. Lymphangiography with lipiodol (a modified poppy seed oil) injection is also a possible therapeutic approach for lymphatic leakage. The mechanism by which it reduces lymphatic leaks has not yet been fully clarified, but it is thought to block lymphatic ducts15.

To the best of our knowledge, no cases of conservative outpatient management have been reported to date. Conservative outpatient management prevents extended hospital stays and the need of parenteral nutrition. In addition, it avoids delaying the beginning of adjuvant chemotherapy, an important factor due to generalized concern for increased risk of tumour recurrence following CL8.

There is limited literature on the prevention of CL. Giovanni et al.14 and Ha et al.16 suggest CL cannot always be prevented due to the inconsistent anatomy of the lymphatic system. However, Baek et al.2 report that meticulous dissection and the use of vascular clips for vascular ligation, rather than electrosurgical devices, can minimize its occurrence. Agustsdottir et al.10 suggest the routine implementation of a low-fat diet during the first three postoperative days in patients undergoing extended lymphadenectomy to prevent CL.

In conclusion, CL is an infrequent complication after colorectal surgery. However, because of the rise in the number of CME, the occurrence of CL should be closely monitored after this type of surgery. Although most cases resolve without surgical intervention, it usually entails prolonged hospital stays and a significant increase in the morbidity. We present the first described case of a successful outpatient treatment, demonstrating that outpatient management is possible; moreover, it has economic and quality of life advantages for the patient, and avoids delaying the adjuvant treatment. Further studies are needed to establish an outpatient management protocol. Dissemination of our results may help inform on alternative effective treatment options.

Acknowledgements

Not applicable.

REFERENCES

1. Lv S, Wang Q, Zhao W, Han L, Wang Q, Batchu N et al. A review of the postoperative lymphatic leakage. Oncotarget 2017; 8(40): 69062-69075. https://doi.org/10.18632/oncotarget.17297 [ Links ]

2. Baek SJ, Kim SH, Kwak JM, Kim J. Incidence and risk factors of chylous ascites after colorectal cancer surgery. Am J Surg 2013; 206(4): 555-559. https://doi.org/10.1016/j.amjsurg.2013.01.033 [ Links ]

3. Lee SY, Kim CH, Kim YJ, Kim HR. Chylous ascites after colorectal cancer surgery: risk factors and impact on short-term and long-term outcomes. Langenbecks Arch Surg 2016; 401(8): 1171-1177. https://doi.org/10.1007/s00423-016-1500-6 [ Links ]

4. Zheng HD, Liu YR, Chen ZZ, Sun YF, Xu CH, Xu JH. Nomogram for predicting chylous ascites after right colectomy. World J Gastrointest Surg 2021; 13(11): 1361-1371. https://doi.org/10.4240/wjgs.v13.i11.1361 [ Links ]

5. Ng ZQ, Han M, Beh HN, Keelan S. Chylous ascites in colorectal surgery: A systematic review. World J Gastrointest Surg 2021; 13(6): 585-596. https://doi.org/10.4240/wjgs.v13.i6.585 [ Links ]

6. Sun YW, Chi P, Lin HM, Lu XR, Huang Y, Xu ZB, et al. Risk factors of postoperative chyle leak following complete mesocolic excision for colon cáncer. [Abstract]. Zhonghua Wei Chang Wai Ke Za Zhi 2012; 15: 328-331. [ Links ]

7. Nishigori H, Ito M, Nishizawa Y, Koda T, Nakajima K, Minagawa N et al. Postoperative chylous ascites after colorectal cancer surgery. Surg Today 2012; 42: 724-728. https://doi.org/10.1007/s00595-012-0132-x [ Links ]

8. Matsuda T, Fujita H, Kunimoto Y, Kimura T, Ogino K. Chylous ascites as a complication of laparoscopic colorectal surgery. Asian J Endosc Surg 2013; 6(4): 279-284. https://doi.org/10.1111/ases.12057 [ Links ]

9. Brewer CF, Al-Abed Y. Chyle leak following total colectomy for ulcerative colitis: a case report and review of the literature. Ann R Coll Surg Engl 2021; 103(7): e231-e233. https://doi.org/10.1308/rcsann.2020.7112 [ Links ]

10. Agustsdottir EES, Stimec BV, Stroemmen TT, Sheikh AE, Elaiyarajah I, Lindstroem JC et al. Preventing chylous ascites after right hemicolectomy with D3 extended mesenterectomy. Langenbecks Arch Surg 2020; 405(7): 1017-1024. https://doi.org/10.1007/s00423-020-01938-4. [ Links ]

11. Shimajiri H, Egi H, Yamamoto M, Kochi M, Mukai S, Ohdan H. Laparoscopic management of refractory chylous ascites using fluorescence navigation with indocyanine green: A case report. Int J Surg Case Rep 2018; 49: 149-152. https://doi.org/10.1016/j.ijscr.2018.06.008 [ Links ]

12. Sriram K, Meguid RA, Meguid MM. Nutritional support in adults with chyle leaks. Nutrition 2016; 32(2): 281-286. https://doi.org/10.1016/j.nut.2015.08.002 [ Links ]

13. Weniger M, D'Haese JG, Angele MK, Kleespies A, Werner J, Hartwig W. Treatment options for chylous ascites after major abdominal surgery: a systematic review. Am J Surg 2016; 211(1): 206-213. https://doi.org/10.1016/j.amjsurg.2015.04.012 [ Links ]

14. Giovannini I, Giuliante F, Chiarla C Ardito F, Vellone M, Nuzzo G. Non-surgical management of a lymphatic fistula, after laparoscopic colorectal surgery, with total parenteral nutrition, octreotide, and somatostatin. Nutrition 2005; 21(10): 1065-1067. https://doi.org/10.1016/j.nut.2005.04.003 [ Links ]

15. Sommer CM, Pieper CC, Itkin M, Nadolski GJ, Hur S, Kim J et al. Conventional lymphangiography (CL) in the management of postoperative lymphatic leakage (PLL): a systematic review. Rofo 2020; 192(11): 1025-1035. https://doi.org/10.1055/a-1131-7889 [ Links ]

16. Ha GW, Lee MR. Surgical repair of intractable chylous ascites following laparoscopic anterior resection. World J Gastroenterol 2015; 21(19): 6077-6081. https://doi.org/10.3748/wjg.v21.i19.6077 [ Links ]

FundingThis research received no external funding.

Ethical statementConfidentiality of data. The authors declare that they have followed the protocols of their work center on the publication of patient data.

Cite as:Rubio López L, Benito Barbero S, Páramo Zunzunegui J, Antón Bravo T, Moral Gonzalez M. Succesful outpatient conservative management of chylous leak after laparoscopic left hemicolectomy. An Sist Sanit Navar 2023; 46(3): e1051. https://doi.org/10.23938/ASSN.1051

Received: September 05, 2023; Revised: September 13, 2023; Accepted: October 03, 2023

Corresponding author: Laura Rubio López - lrubiol@salud.madrid.org

Conflict of interest

The authors declare that they have no conflicts of interest to disclose.

Authors contribution

Conceptualization: LRL, MMG, JPZ

Writing - Original Draft: LRL

Writing - Review and Editing: MMG, SBB, TAB

Creative Commons License This is an open-access article distributed under the terms of the Creative Commons Attribution Share-Alike License